迈向建立囊性纤维化新的临床终点：肺清除指数和心肺运动试验的作用。
Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing.
作者信息
Hatziagorou Elpis, Kampouras Asterios, Avramidou Vasiliki, Toulia Ilektra, Chrysochoou Elisavet-Anna, Galogavrou Maria, Kirvassilis Fotios, Tsanakas John
机构信息
Pediatric Pulmonology and Cystic Fibrosis Unit, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
出版信息
Front Pediatr. 2021 Feb 25;9:635719. doi: 10.3389/fped.2021.635719. eCollection 2021.
Abstract
As Cystic Fibrosis (CF) treatment advances, research evidence has highlighted the value and applicability of Lung Clearance Index and Cardiopulmonary Exercise Testing as endpoints for clinical trials. In the context of these new endpoints for CF trials, we have explored the use of these two test outcomes for routine CF care. In this review we have presented the use of these methods in assessing disease severity, disease progression, and the efficacy of new interventions with considerations for future research.
摘要
随着囊性纤维化（CF）治疗的进展，研究证据凸显了肺清除指数和心肺运动试验作为临床试验终点的价值和适用性。在CF试验的这些新终点的背景下，我们探讨了将这两种测试结果用于CF常规护理的情况。在本综述中，我们介绍了这些方法在评估疾病严重程度、疾病进展以及新干预措施疗效方面的应用，并对未来研究进行了思考。
相似文献
1
Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing.
Front Pediatr. 2021 Feb 25;9:635719. doi: 10.3389/fped.2021.635719. eCollection 2021.
2
Lung clearance index (LCI) as a predictor of exercise limitation among CF patients.
Pediatr Pulmonol. 2018 Jan;53(1):81-87. doi: 10.1002/ppul.23833. Epub 2017 Sep 26.
3
In cystic fibrosis, lung clearance index is sensitive to detecting abnormalities appearing at exercise in children with normal spirometry.
Respir Physiol Neurobiol. 2018 Jan;247:9-11. doi: 10.1016/j.resp.2017.08.017. Epub 2017 Sep 4.
4
Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis.
Am J Respir Crit Care Med. 2017 Feb 1;195(3):349-359. doi: 10.1164/rccm.201604-0893OC.
5
Lung clearance index in the assessment of airways disease.
Respir Med. 2009 Jun;103(6):793-9. doi: 10.1016/j.rmed.2009.01.025. Epub 2009 Feb 25.
6
Lung clearance index: evidence for use in clinical trials in cystic fibrosis.
J Cyst Fibros. 2014 Mar;13(2):123-38. doi: 10.1016/j.jcf.2013.09.005. Epub 2013 Dec 5.
7
Cardiopulmonary exercise testing in children with cystic fibrosis: one centre's experience.
Arch Dis Child. 2017 May;102(5):440-444. doi: 10.1136/archdischild-2016-310651. Epub 2016 Dec 5.
8
Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis.
Am J Respir Crit Care Med. 2019 Apr 15;199(8):987-995. doi: 10.1164/rccm.201806-1110OC.
9
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool.
Respir Med. 2020 Apr;164:105906. doi: 10.1016/j.rmed.2020.105906. Epub 2020 Feb 19.
10
The lung clearance index as a monitoring tool in cystic fibrosis: ready for the clinic?
Curr Opin Pulm Med. 2018 Nov;24(6):579-585. doi: 10.1097/MCP.0000000000000515.
引用本文的文献
1
Impact of CFTR modulators on exercise capacity in adolescents with cystic fibrosis.
ERJ Open Res. 2024 Feb 19;10(1). doi: 10.1183/23120541.00687-2023. eCollection 2024 Jan.
2
Exercise as an Airway Clearance Technique in people with Cystic Fibrosis (ExACT-CF): rationale and study protocol for a randomised pilot trial.
NIHR Open Res. 2022 Dec 19;2:64. doi: 10.3310/nihropenres.13347.1. eCollection 2022.
3
Survey of exercise testing and training in cystic fibrosis clinics in the UK: a decade of progress.
BMJ Open. 2023 Apr 28;13(4):e072461. doi: 10.1136/bmjopen-2023-072461.
4
Time Free From Hospitalization in Children and Adolescents With Cystic Fibrosis: Findings From FEV, Lung Clearance Index and Peak Work Rate.
Front Pediatr. 2022 Jun 22;10:926248. doi: 10.3389/fped.2022.926248. eCollection 2022.
5
Disconcerting and Counterintuitive Findings from a Trial of Exercise in Cystic Fibrosis: Can Exercise Make Our Patients Worse?
Am J Respir Crit Care Med. 2022 Feb 1;205(3):269-270. doi: 10.1164/rccm.202110-2446ED.
6
Ventilatory efficiency and its clinical and prognostic value in adults with cystic fibrosis.
Eur Respir Rev. 2021 Nov 30;30(162). doi: 10.1183/16000617.0395-2020. Print 2021 Dec 31.
本文引用的文献
1
VO as an exercise tolerance endpoint in people with cystic fibrosis: Lessons from a lumacaftor/ivacaftor trial.
J Cyst Fibros. 2021 May;20(3):499-505. doi: 10.1016/j.jcf.2020.12.006. Epub 2020 Dec 24.
2
Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic Fibrosis.
Am J Respir Crit Care Med. 2021 Apr 15;203(8):977-986. doi: 10.1164/rccm.202006-2433OC.
3
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation.
J Cyst Fibros. 2021 Jan;20(1):68-77. doi: 10.1016/j.jcf.2020.07.023. Epub 2020 Sep 21.
4
Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment.
Pediatr Pulmonol. 2020 Dec;55(12):3364-3370. doi: 10.1002/ppul.25059. Epub 2020 Sep 19.
5
An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa.
BMC Pulm Med. 2020 Jun 12;20(1):167. doi: 10.1186/s12890-020-01201-y.
6
Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study.
J Cyst Fibros. 2020 Nov;19(6):931-933. doi: 10.1016/j.jcf.2020.05.010. Epub 2020 Jun 6.
7
An observational study of the lung clearance index throughout childhood in cystic fibrosis: early years matter.
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.00006-2020. Print 2020 Oct.
8
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool.
Respir Med. 2020 Apr;164:105906. doi: 10.1016/j.rmed.2020.105906. Epub 2020 Feb 19.
9
Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one year.
J Cyst Fibros. 2020 Nov;19(6):896-901. doi: 10.1016/j.jcf.2020.01.006. Epub 2020 Feb 7.
10
Exercise capacity and ventilation inhomogeneity in cystic fibrosis: A cross-sectional study.
Pediatr Pulmonol. 2020 Feb;55(2):394-400. doi: 10.1002/ppul.24525.
Zotero 插件